FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biochemistry. What is presented is a conjugate of hyaluronic acid and novocaine of a structure as defined in the patent claim containing 20-50% residues of novocaine.
EFFECT: conjugate is water-soluble; it possess the amphoteric properties and contains no side O-acylisourea.
3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PRODUCTION METHOD OF LOW-WATER-SOLUBLE HARD MATERIALS BASED ON CARBOXYL-CONTAINING POLYSACCHARIDES MODIFIED WITH AMINOSALICYLIC ACID | 2007 |
|
RU2343932C1 |
HYALURONIC ACID DERIVATIVES OF LOWERED BIODEGRADABILITY | 2007 |
|
RU2350625C2 |
METHOD FOR PRODUCTION OF MODIFIED DERMATHANE SULFATE | 2005 |
|
RU2318830C2 |
ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
ANTI-INFLAMMATORY AND ANTINEOPLASTIC ANTICOAGULANT | 2009 |
|
RU2408379C2 |
AGENT FOR HAIR GROWTH STIMULATION | 2012 |
|
RU2505301C2 |
METHOD FOR PRODUCTION OF MODIFIED ARABINOGALACTAN | 2007 |
|
RU2359975C2 |
METHOD OF MODIFIED HYALURONIC ACID PREPARING | 2000 |
|
RU2191782C2 |
METHOD OF PRODUCING CHONDROITIN-6-SULPHATE FROM UMBILICAL CORDS OF NEWLY BORN BABIES | 2008 |
|
RU2383351C2 |
STRAIN OF BACTERIA STREPTOMYCES VIOLASCENS - PRODUCER OF HYALURONIC ACID | 2019 |
|
RU2720287C1 |
Authors
Dates
2013-01-27—Published
2011-01-12—Filed